Group 6 Copy 342
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Metabolizing Microplastics for Human Health

    Plastics have revolutionized material science engineering. However, the use of plastic has had unintended...

    Can immune cells prevent 3D printed blood vessels from falling apart?

    Mass production of cells is limited by nutrient delivery. 3D printing of hydrogel has enabled the printing...

    Can we find a low cost solution to store temperature sensitive enzymes in research?

    Temperature-sensitive reagents are common in biology labs, and often need to be stored in expensive ultra...

    Backer Badge Funded